Suppr超能文献

HIV 根除策略:对中枢神经系统的影响。

HIV Eradication Strategies: Implications for the Central Nervous System.

机构信息

Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Vaccine Research Center - NIAID - NIH, Bethesda, MD, USA.

出版信息

Curr HIV/AIDS Rep. 2019 Feb;16(1):96-104. doi: 10.1007/s11904-019-00428-7.

Abstract

PURPOSE OF REVIEW

In addition to preventive protocols and antiretroviral therapy, HIV-1 eradication has been considered as an additional strategy to help fight the AIDS epidemic. With the support of multiple funding agencies, research groups worldwide have been developing protocols to achieve either a sterilizing or a functional cure for HIV-infection.

RECENT FINDINGS

Most of the studies focus on the elimination or suppression of circulating CD4+ T cells, the best characterized HIV-1 latent reservoir. The role of the central nervous system (CNS) as a latent reservoir is still controversial. Although brain macrophages and astrocytes are susceptible to HIV-1 infection, it has not been ascertained whether the CNS carries latent HIV-1 during cART and, if so, whether the virus can be reactivated and spread to other compartments after ART interruption. Here, we examine the implications of HIV-1 eradication strategies on the CNS, regardless of whether it is a true latent reservoir and, if so, whether it is present in all patients.

摘要

目的综述:除了预防方案和抗逆转录病毒疗法之外,HIV-1 的根除也被认为是帮助对抗艾滋病流行的一种额外策略。在多个资助机构的支持下,全球研究小组一直在制定方案,以实现 HIV 感染的根治或功能性治愈。

最近发现:大多数研究集中在消除或抑制循环 CD4+T 细胞上,这是 HIV-1 潜伏库中最好的特征。中枢神经系统(CNS)作为潜伏库的作用仍存在争议。尽管脑巨噬细胞和星形胶质细胞易受 HIV-1 感染,但尚不确定在 cART 期间中枢神经系统是否携带潜伏的 HIV-1,如果是,病毒在 ART 中断后是否可以被重新激活并传播到其他部位。在这里,我们研究了 HIV-1 根除策略对中枢神经系统的影响,无论中枢神经系统是否是真正的潜伏库,以及如果是,是否存在于所有患者中。

相似文献

1
HIV Eradication Strategies: Implications for the Central Nervous System.
Curr HIV/AIDS Rep. 2019 Feb;16(1):96-104. doi: 10.1007/s11904-019-00428-7.
2
The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.
Curr HIV/AIDS Rep. 2015 Jun;12(2):299-303. doi: 10.1007/s11904-015-0257-9.
3
A Quantitative Approach to SIV Functional Latency in Brain Macrophages.
J Neuroimmune Pharmacol. 2019 Mar;14(1):23-32. doi: 10.1007/s11481-018-9803-8. Epub 2018 Aug 30.
4
Perspective on potential impact of HIV central nervous system latency on eradication.
AIDS. 2019 Dec 1;33 Suppl 2:S123-S133. doi: 10.1097/QAD.0000000000002264.
6
HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
J Neurovirol. 2015 Jun;21(3):290-300. doi: 10.1007/s13365-014-0271-5. Epub 2014 Jul 25.
7
HIV reservoirs and strategies for eradication.
Curr HIV/AIDS Rep. 2012 Mar;9(1):5-15. doi: 10.1007/s11904-011-0108-2.
8
Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors.
AIDS Res Hum Retroviruses. 2019 Jan;35(1):1-24. doi: 10.1089/AID.2018.0153. Epub 2018 Dec 12.
9
Mathematical Models of HIV Latency.
Curr Top Microbiol Immunol. 2018;417:131-156. doi: 10.1007/82_2017_77.
10
Microglial Cells: The Main HIV-1 Reservoir in the Brain.
Front Cell Infect Microbiol. 2019 Oct 24;9:362. doi: 10.3389/fcimb.2019.00362. eCollection 2019.

引用本文的文献

1
Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
PLoS Pathog. 2024 Sep 24;20(9):e1012470. doi: 10.1371/journal.ppat.1012470. eCollection 2024 Sep.
2
Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
AIDS. 2024 Nov 15;38(14):1972-1977. doi: 10.1097/QAD.0000000000004000. Epub 2024 Aug 28.
5
The reservoir of latent HIV.
Front Cell Infect Microbiol. 2022 Jul 28;12:945956. doi: 10.3389/fcimb.2022.945956. eCollection 2022.
7
HIV Latency in Myeloid Cells: Challenges for a Cure.
Pathogens. 2022 May 24;11(6):611. doi: 10.3390/pathogens11060611.
8
9
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques.
PLoS Pathog. 2021 Jul 20;17(7):e1009738. doi: 10.1371/journal.ppat.1009738. eCollection 2021 Jul.

本文引用的文献

1
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.
Oncoimmunology. 2018 May 24;7(8):e1466769. doi: 10.1080/2162402X.2018.1466769. eCollection 2018.
2
Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
N Engl J Med. 2018 Sep 6;379(10):979-981. doi: 10.1056/NEJMc1807653. Epub 2018 Jul 24.
5
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.
Immunity. 2018 Apr 17;48(4):760-772.e4. doi: 10.1016/j.immuni.2018.03.012. Epub 2018 Apr 3.
6
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Blood. 2018 Jun 7;131(23):2515-2527. doi: 10.1182/blood-2017-12-823757. Epub 2018 Feb 20.
8
The Dynamic Interplay between HIV-1, SAMHD1, and the Innate Antiviral Response.
Front Immunol. 2017 Nov 10;8:1541. doi: 10.3389/fimmu.2017.01541. eCollection 2017.
10
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4 T cells from HIV-1 infection.
Cell Biosci. 2017 Sep 9;7:47. doi: 10.1186/s13578-017-0174-2. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验